Skip to Main Content

Paper Details

INCREASING EVIDENCE FOR THE SAFETY OF FOVEA-INVOLVING HALF-DOSE PHOTODYNAMIC THERAPY FOR CHRONIC CENTRAL SEROUS CHORIORETINOPATHY.
Retina
6
2023
Author NameAffiliation
Carel B HoyngRadboud University Medical Center
  • 1 - 1

Datasets

Release 1.2